This inventor holds 3 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1985-1990.
Location History:
- Swindon, GB (1985 - 1987)
- Swindon Wilts, GB (1990)
Company Filing History:
Years Active: 1985-1990
Title: The Innovative Contributions of Roger J Gillespie
Introduction
Roger J Gillespie is a notable inventor based in Swindon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents to his name, Gillespie's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Gillespie's latest patents include innovative compounds such as 2-thiazolyl-imidazo[1,2,-a]pyrimidines. This compound is characterized by its unique formula, where R1 is thiazol-2-yl, which may be substituted by alkyl groups or fluorine. The compound is designed for the treatment of obesity and cognitive impairment, showcasing its minor tranquillizing activity. Another significant patent involves 2-(1,2,4-oxadiazol-5-yl), which includes a range of novel compounds with anxiolytic, sedative, and hypnotic properties. These compounds are also designed to be non-toxic and pharmaceutically acceptable, further emphasizing Gillespie's commitment to safety and efficacy in drug development.
Career Highlights
Roger J Gillespie has built a reputable career at Roussel Uclaf, where he has focused on pharmaceutical innovations. His work has not only contributed to the advancement of medical science but has also positioned him as a key figure in the industry. His dedication to research and development has led to the creation of compounds that address critical health issues.
Collaborations
Gillespie has collaborated with esteemed colleagues such as Wilfred R Tully and Colin R Gardner. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical field.
Conclusion
In summary, Roger J Gillespie is a distinguished inventor whose work in pharmaceuticals has led to the development of important therapeutic compounds. His contributions are vital to advancing medical treatments and improving patient outcomes.